H. Ralph Schumacher, Jr., MD, has a zest for research
Coding Corner Question
January’s Coding Challenge
Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease
A perspective on B cell–targeted therapies in autoimmune disease
Sex Differences & Rheumatoid Arthritis
The beliefs versus the data
Chance Discovery May Provide RA Diagnostic
Science From Arthritis & Rheumatism
From Paper to Practice
Using ACR RA recommendations to improve quality of care
PQRI Now Includes RA Measures Group
In 2008, the only Physician Quality Reporting Initiative (PQRI) measure that applied to rheumatoid arthritis (RA) was disease-modifying antirheumatic drug therapy. For 2009, five new RA measures were included, for a total of six measures in the new RA Measures Group. The five new measures were developed in 2008 by the National Committee for Quality Assurance in collaboration with the ACR and the American Medical Association’s Physician Consortium for Performance Improvement and were subsequently adopted by Medicare.
Know Your Labs, Part 2
A review of testing for rheumatoid arthritis
Meet the HEP C Challenge
Keep a hepatitis C virus infection from hindering RA treatment
Patient Fact Sheet: Rheumatoid Arthritis
Rheumatoid arthritis (RA), the most common form of inflammatory arthritis, is a chronic disease that causes pain, stiffness, swelling, and limitation in the motion and function of multiple joints. RA is classified as an autoimmune disease, which develops because certain cells of the immune system malfunction and attack healthy joints.
- « Previous Page
- 1
- …
- 66
- 67
- 68
- 69
- 70
- …
- 73
- Next Page »